Can slight variations in lab environments affect the malaria-causing parasite (Plasmodium) and its tolerance to anti-malarial drugs? Griffith University’s Sandra Duffy believes it’s possible.
Griffith University scientists have helped discover new compounds which could help block the transmission of the deadly disease malaria. A team of Griffith researchers has found a novel class of compounds, the hexahydro quinoline (HHQ), with potent activity against the parasite stages responsible for the clinical symptoms of malaria and its transmission to mosquitoes.
Leading Griffith University researchers have been honoured at the Vice Chancellor’s Research Excellence Awards held at the Gold Coast campus.
A “Malaria Box” that could hold the answer to discovering new drugs to treat tropical diseases and cancer has been created for researchers around the world. Griffith University tropical disease researchers have joined together with a host of international laboratories to advance drug discovery for major topical diseases through the creation and testing of the […]
Griffith University researchers are tackling the enormous global health problem of malaria through innovative approaches to develop new vaccine and drug candidates. At Griffith’s two leading biomedical research institutes – the Institute for Glycomics and the Eskitis Institute for Drug Discovery – research teams are firmly focused on, and are making progress towards the global […]
Scientists from Griffith University have contributed to a breakthrough identifying and characterising a potent agent that thwarts drug resistance in the parasite that causes malaria. In a paper published in the journal Science Translational Medicine, an international research team is reporting the effectiveness of DSM265, a long-acting inhibitor for the treatment and prevention of malaria and which […]
Dedicated researchers from Griffith's Eskitis Institute for Drug Discovery are winning acclaim and taking their work to the world